60 Degrees Pharmaceuticals Free Cash Flow (FCF) History (SXTP)

60 Degrees Pharmaceuticals reported −$7.0M in free cash flow for fiscal 2025, a decrease of $1.2M from the previous fiscal year, with a free cash flow margin of −695.09%.

View full 60 Degrees Pharmaceuticals company overview

60 Degrees Pharmaceuticals free cash flow by year

60 Degrees Pharmaceuticals annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20252025-12-31−$7.0M−$1.2M−695.09%
20242024-12-31−$5.8M−$1.2M−946.69%
20232023-12-31−$4.6M−$3.5M−1814.28%
20222022-12-31−$1.1M−479.42%

60 Degrees Pharmaceuticals free cash flow growth trends

60 Degrees Pharmaceuticals's latest reported quarter, Q2 2026, generated −$2.2M in free cash flow, a decrease of $734,270 year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review 60 Degrees Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about SXTP yet. Start the conversation.

Write the first post